Green Alpha Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,341
Closed -$782K 147
2023
Q4
$782K Hold
1,341
0.56% 76
2023
Q3
$720K Hold
1,341
0.55% 67
2023
Q2
$629K Hold
1,341
0.41% 90
2023
Q1
$461K Hold
1,341
0.32% 109
2022
Q4
$491K Buy
+1,341
New +$475K 0.41% 99

Other funds holding LLY

Green Alpha Advisors's LLY Position: Q1 2024 in Review

Green Alpha Advisors sold out of Eli Lilly (LLY) in Q1 2024, closing a stake of 1,341 shares — an estimated $782K sold.

Green Alpha Advisors first reported a position in LLY in Q4 2022 and held it in 5 quarters. The position peaked at $782K in Q4 2023. 3,466 funds tracked by Wall St. Rank hold LLY as of Q1 2024.

  • Green Alpha Advisors reported no remaining Eli Lilly position as of Q1 2024 after selling out during the quarter.
  • Green Alpha Advisors sold 1,341 Eli Lilly shares in Q1 2024, an estimated $782K.
  • Green Alpha Advisors first reported a position in Eli Lilly in Q4 2022 and held it in 5 quarters.
  • Green Alpha Advisors's Eli Lilly position peaked at $782K in Q4 2023.
  • 3,466 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2024.

Based on Green Alpha Advisors's 13F filing for Q1 2024, filed 10 Apr 2024.